Blackstone Life Sciences — Full Portfolio

Apogee Therapeutics develops engineered antibody therapies to treat inflammatory and immune diseases with reduced injection frequency compared to existing treatments.

BiotechHealthtechMedical Devices

MHMichael Henderson(Chief Executive Officer and Director)in

Co-investorsACAccess BiotechnologyRARA CapitalWEWellington ManagementPEPerceptive Xontogeny VentureRTRTW Investments L.P.VEVenrock Healthcare Capital Partners

AvenCell Therapeutics develops next-generation cell therapies for hard-to-treat cancers, including solid tumors, combining switchable universal CAR-T technology with a CRISPR/Cas9-based allogeneic platform.

BiotechLongevityMedical Devices

ASAndrew Schiermeier(Chief Executive Officer)in

Co-investorsNONovo HoldingsEIEight Roads VenturesF-F-Prime CapitalNYNYBC Ventures

Anagram builds insurance infrastructure for eye care providers, offering a connected platform for eligibility, benefits, claims, and payments along with revenue cycle management that automates billing and collections.

FintechHealthtechInsurTechSaaS

Co-investorsFUFundersClubWAWaterline VenturesHEHealthy VenturesKEKEC VenturesKIKickstartNENextView Ventures

Anagram builds software to help eye care providers manage vision insurance, lab ordering, and administrative workflows so they can deliver better patient care affordably.

Enterprise SoftwareHealthtechInsurTechSaaS

AWAustin Winfield(Founder)in

Co-investorsGRGreatPoint VenturesHEHealthy VenturesMAManchesterStory Group, LLCWAWaterline VenturesKEKEC VenturesKIKickstart+1 more

Anagram describes itself as an institution focused on crypto and the "ownership economy," offering staking services and deploying human and financial capital in the space.

Crypto & Web3

AWAustin Winfield(Founder)in

Co-investorsMAMarin Digital VenturesHEHealthy VenturesKEKEC VenturesKIKickstartNENextView VenturesWAWaterline Ventures

Annexon is a clinical-stage biopharmaceutical company developing C1q and classical complement pathway inhibitors to treat complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders.

BiotechHealthtechMedical DevicesSo. San Francisco, US

Ben Barres(Scientific Co-Founder)DLDouglas Love(Founder)inMark L Smith(Executive Officer)CMCampbell Murray(Director)inThomas Wiggans(Director)RSRicky Sun(Director)

Co-investorsBABain Capital Life SciencesCOCorrelation VenturesNENew Enterprise Associates (NEA)BLBlackRockCLClarus VenturesDEDeerfield Management Company+2 more

Banner builds software for commercial real estate owners and teams to manage capital spending across a property's lifecycle, consolidating communications, workflows, spreadsheets, and file-sharing into one system.

Enterprise SoftwareMarketplacesPropTechSaaSNew York City, US

KCKunal Chaudhary(Co-founder)inEric Gao(Co-founder)inMark Murphy(Founder)Kishan S(Senior Product Manager)James Lindberg(Head of Sales)Michael Feinstein(Director of Eng)

Co-investorsAMAmino CapitalBABasis Set VenturesPRPruVen Capital PartnersSISidekick PartnersY Y CombinatorCOContrary+2 more

Engine (formerly Hotel Engine) operates a business travel management platform that connects companies with lodging, flights, and car rentals to book and manage trips.

FintechMarketplacesSaaSTravel & Hospitality

Elia(CEO)Elia Wallen(Founder)Petar Besevic(Founder)Simon Spurrier(Founder)

Co-investorsELElefundTETelescope PartnersENEntrepreneur First

Revore builds return and collection systems for reusable packaging and other returnable items, deployed at indoor sites such as offices, airports, universities, hospitals, pharmacies, retail chains, quick-service restaurants, and event arenas.

Circular EconomyCleantechHardware

Co-investorsFIFintech AngelsHEHeadlineKIKickstart InnovationBOBond Capital ManagementBUBullpen CapitalLOlone pine capital

A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.

BiotechHealthtech

Co-investorsFRFrazier Life SciencesHIHighlight CapitalMRMRL Ventures FundXEXeraya CapitalAMAmgen VenturesBLBlackRock+5 more

LRN provides ethics and compliance software, analytics, and training that help organizations manage policies, employee reporting, codes of conduct, and regulatory compliance programs.

EdTechEnterprise SoftwareSaaS

Dov Seidman(Founder)

Co-investorsINInsight Partners

Moderna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.

BiotechDeep TechMedical DevicesCambridge, US

RLRobert Langer(Founder)NANoubar Afeyan, Ph.D.(Co-founder and Chairman, Moderna; CEO, Flagship Pioneering)LKLorence Kim(Executive Officer)inJRJames R. Kasinger(Executive Officer)inSHStephen Hoge(Executive Officer)inDerrick Rossi(Founder)

Co-investorsAGAglae VenturesFLFlagship PioneeringFPFPVKHKhosla VenturesLILingottoPRPremji Invest+5 more

Mollie provides in-person payment tools for European businesses, including card terminals, mobile and fixed POS terminals, and tap-to-pay apps for iPhone and Android, all managed through a central dashboard.

E-commerceFintechRetail TechSaaS

AMAdriaan Mol(Founder)in

Co-investorsALAlkeon InnovationFEFelicis VenturesGEGeneral AtlanticKEKeen Venture PartnersTCTCVALAlkeon Capital+2 more

Zhong Shanshan(Founder)

Norm Ai builds AI agents that automate legal and compliance tasks for large institutions, along with a verification layer for AI agents and an affiliated AI-native law firm.

AI & Machine LearningEnterprise SoftwareLegalTechNew York, US

JNJohn Nay(Founder)inMike Schmidtberger(Chairman and Partner, Norm Law)in

Co-investorsBABain Capital VenturesCOCoatue ManagementCRCraft VenturesKHKhosla VenturesBABain CapitalBLBlackstone+11 more

AI company developing a medical search engine used by physicians for clinical decision support.

DNDaniel Nadler(Founder)inZZZachary Ziegler(Founder)Daniel Nadler Zachary Ziegler(Founder)Zack Ziegler(Founder)

Co-investorsALAlkeon InnovationAMAmity VenturesANAndreessen HorowitzBABas1s VenturesBOBond Capital ManagementBRBreyer Capital+28 more

Clinical-stage biotech developing cell therapy products for transplant and autoimmune conditions

BiotechLouisville, US

Suzanne Ildstad(Executive Officer, Director)SRScott Requadt(Executive Officer, Director)Geoff Mackay(Director)Francois Nader(Director)

BoardSASandip Agarwala(Director)inMMMark McDade(Director)in

Co-investorsAIAisling CapitalKEKeyhorse CapitalLOLongitude CapitalQIQiming Venture Partners USAVIViking GlobalCICitadel+3 more